Literature DB >> 19666214

Prevalence of psychotic and non-psychotic disorders in relatives of patients with a first episode psychosis.

Kia Faridi1, Nicole Pawliuk, Suzanne King, Ridha Joober, Ashok K Malla.   

Abstract

BACKGROUND: Family members of individuals with schizophrenia suffer from elevated rates of schizophrenia-spectrum disorders (SSD) and other forms of psychopathology. However, few studies have examined familial psychopathology in probands with a first episode of psychosis (FEP). We systematically evaluated family history in patients experiencing an affective or non-affective FEP.
METHODS: The Family Interview for Genetic Studies was used to obtain diagnostic information on all first- and second-degree relatives of probands admitted to a specialized FEP program. Probands were 94 previously untreated patients suffering from a first-episode of affective or schizophrenia spectrum psychosis, aged 14 to 30. The interview ascertained diagnoses of psychotic disorders, affective disorders, substance-use disorders (SUD), and schizophrenia-related personality disorders.
RESULTS: One in five probands (19.1%) had a history of psychosis among their first-degree relatives, while 34.0% had any relative with psychosis. Fewer probands had a family history of SSD (7.4% with a first-degree history and 18.1% with a history among any relatives). Over half (53.2%) of probands had a first-degree relative with Major Depressive Disorder, and 38.3% had a first-degree relative with a SUD. Overall, 69.9% of probands had a first-degree relative with a mental disorder. The proportion of probands with a family history of any of these diagnoses did not vary by proband diagnosis (affective or SS Psychosis), though probands with co-morbid SUD were more likely to have a family history of substance abuse.
CONCLUSIONS: Diverse psychopathology is commonly present in families of FEP patients and may imply a generalized vulnerability to psychiatric disorders to be greater in such families compared to specific vulnerability to SS or affective psychosis. These findings may also have implications for provision of care for the probands.

Entities:  

Mesh:

Year:  2009        PMID: 19666214     DOI: 10.1016/j.schres.2009.07.007

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  15 in total

1.  Latina Mothers Caring for a Son or Daughter with Autism or Schizophrenia: Similarities, Differences and the Relationship Between Co-Residency and Maternal Well-Being.

Authors:  Sandy Magaña; Subharati Ghosh
Journal:  J Fam Soc Work       Date:  2010-05-01

2.  Comparison of children with autism spectrum disorder with and without schizophrenia spectrum traits: gender, season of birth, and mental health risk factors.

Authors:  Kenneth D Gadow; Carla J DeVincent
Journal:  J Autism Dev Disord       Date:  2012-11

3.  Psychosis risk is associated with decreased white matter integrity in limbic network corticostriatal tracts.

Authors:  Kelsey T Straub; Jessica P Y Hua; Nicole R Karcher; John G Kerns
Journal:  Psychiatry Res Neuroimaging       Date:  2020-05-15       Impact factor: 2.376

4.  Probabilistic Category Learning and Striatal Functional Activation in Psychosis Risk.

Authors:  Nicole R Karcher; Jessica P Y Hua; John G Kerns
Journal:  Schizophr Bull       Date:  2019-03-07       Impact factor: 9.306

5.  Symptoms of autism and schizophrenia spectrum disorders in clinically referred youth with oppositional defiant disorder.

Authors:  Kenneth D Gadow; Deborah A G Drabick
Journal:  Res Dev Disabil       Date:  2012-03-22

6.  Psychosis risk is associated with decreased resting-state functional connectivity between the striatum and the default mode network.

Authors:  Jessica P Y Hua; Nicole R Karcher; Anne M Merrill; Kathleen J O'Brien; Kelsey T Straub; Timothy J Trull; John G Kerns
Journal:  Cogn Affect Behav Neurosci       Date:  2019-08       Impact factor: 3.282

7.  Striatum-related functional activation during reward- versus punishment-based learning in psychosis risk.

Authors:  Nicole R Karcher; Jessica P Y Hua; John G Kerns
Journal:  Neuropsychopharmacology       Date:  2019-07-04       Impact factor: 7.853

8.  Comorbid substance use disorders in schizophrenia: a latent class approach.

Authors:  Berit Kerner
Journal:  Psychiatry Res       Date:  2014-12-15       Impact factor: 3.222

9.  Morbidity profile of first-degree relatives of probands with schizophrenia: a comparison with mood disorder and healthy control.

Authors:  Adeniran O Okewole; Abiodun O Adewuya; Roger O A Makanjuola; Olugbenga A Owoeye
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-07-24       Impact factor: 4.328

Review 10.  Clinical and molecular genetics of psychotic depression.

Authors:  Katharina Domschke
Journal:  Schizophr Bull       Date:  2013-03-19       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.